Loading clinical trials...
Loading clinical trials...
Evaluation of the Efficacy and Safety of Camostat Mesilate + Hydroxychloroquine Combination Therapy in Hospitalized Patients With Moderate COVID-19 Infection
Conditions
Interventions
Camostat Mesilate
Placebo
+1 more
Start Date
May 1, 2020
Primary Completion Date
December 1, 2021
Completion Date
December 1, 2021
Last Updated
December 21, 2020
NCT06082518
NCT06721949
NCT07221162
NCT06631287
NCT06679140
NCT06417762
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions